FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127574568> ?p ?o ?g. }

• W2127574568 endingPage "30" @default.
• W2127574568 startingPage "6526" @default.
• W2127574568 abstract "Causing prostate cancer cells to express functionally active sodium iodide symporter (NIS) by targeted NIS gene transfer might offer the possibility of radioiodine therapy of prostate cancer. Therefore, we investigated radioiodine accumulation and therapeutic effectiveness of 131I in NIS-transfected prostate cancer cells in vitro and in vivo. The human prostatic adenocarcinoma cell line LNCaP was stably transfected with NIS cDNA under the control of the prostate-specific antigen promoter. The stably transfected LNCaP cell line NP-1 showed perchlorate-sensitive, androgen-dependent iodide uptake in vitro that resulted in selective killing of these cells by 131I in an in vitro clonogenic assay. Xenografts were established in athymic nude mice and imaged using a gamma camera after i.p. injection of 500 microCi of 123I. In contrast to the NIS-negative control tumors (P-1) which showed no in vivo uptake of 123I, NP-1 tumors accumulated 25-30% of the total 123I administered with a biological half-life of 45 h. In addition, NIS protein expression in LNCaP cell xenografts was confirmed by Western blot analysis and immunohistochemistry. After a single i.p. application of a therapeutic 131I dose (3 mCi), significant tumor reduction was achieved in NP-1 tumors in the therapy group compared with P-1 tumors and tumors in the control group. In conclusion, a therapeutic effect of 131I has been demonstrated in prostate cancer cells after induction of tissue-specific iodide uptake activity by prostate-specific antigen promoter-directed NIS expression in vitro and in vivo. This study demonstrates the potential of NIS as a novel therapeutic gene for nonthyroidal cancers, in particular prostate cancer." @default.
• W2127574568 created "2016-06-24" @default.
• W2127574568 creator A5014512900 @default.
• W2127574568 creator A5021821969 @default.
• W2127574568 creator A5031722039 @default.
• W2127574568 creator A5063630764 @default.
• W2127574568 creator A5070640664 @default.
• W2127574568 creator A5085178550 @default.
• W2127574568 date "2000-11-15" @default.
• W2127574568 modified "2023-10-16" @default.
• W2127574568 title "Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter." @default.
• W2127574568 cites W1519583741 @default.
• W2127574568 cites W1973361095 @default.
• W2127574568 cites W1975519041 @default.
• W2127574568 cites W1980226373 @default.
• W2127574568 cites W1992692978 @default.
• W2127574568 cites W1993970313 @default.
• W2127574568 cites W2005953810 @default.
• W2127574568 cites W2015554237 @default.
• W2127574568 cites W2028080080 @default.
• W2127574568 cites W2034083247 @default.
• W2127574568 cites W2047881598 @default.
• W2127574568 cites W2065003195 @default.
• W2127574568 cites W2104568463 @default.
• W2127574568 cites W2113008095 @default.
• W2127574568 cites W2147943356 @default.
• W2127574568 cites W2153876645 @default.
• W2127574568 cites W2161469472 @default.
• W2127574568 cites W2162612481 @default.
• W2127574568 cites W2167124805 @default.
• W2127574568 cites W2331426277 @default.
• W2127574568 cites W2413000262 @default.
• W2127574568 cites W2415518040 @default.
• W2127574568 cites W2416968969 @default.
• W2127574568 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11103823" @default.
• W2127574568 hasPublicationYear "2000" @default.
• W2127574568 type Work @default.
• W2127574568 sameAs 2127574568 @default.
• W2127574568 citedByCount "79" @default.
• W2127574568 countsByYear W21275745682012 @default.
• W2127574568 countsByYear W21275745682013 @default.
• W2127574568 countsByYear W21275745682014 @default.
• W2127574568 countsByYear W21275745682015 @default.
• W2127574568 countsByYear W21275745682016 @default.
• W2127574568 countsByYear W21275745682017 @default.
• W2127574568 countsByYear W21275745682018 @default.
• W2127574568 countsByYear W21275745682019 @default.
• W2127574568 countsByYear W21275745682020 @default.
• W2127574568 countsByYear W21275745682021 @default.
• W2127574568 countsByYear W21275745682022 @default.
• W2127574568 crossrefType "journal-article" @default.
• W2127574568 hasAuthorship W2127574568A5014512900 @default.
• W2127574568 hasAuthorship W2127574568A5021821969 @default.
• W2127574568 hasAuthorship W2127574568A5031722039 @default.
• W2127574568 hasAuthorship W2127574568A5063630764 @default.
• W2127574568 hasAuthorship W2127574568A5070640664 @default.
• W2127574568 hasAuthorship W2127574568A5085178550 @default.
• W2127574568 hasConcept C104317684 @default.
• W2127574568 hasConcept C117262875 @default.
• W2127574568 hasConcept C120405084 @default.
• W2127574568 hasConcept C121608353 @default.
• W2127574568 hasConcept C126322002 @default.
• W2127574568 hasConcept C149011108 @default.
• W2127574568 hasConcept C150903083 @default.
• W2127574568 hasConcept C185592680 @default.
• W2127574568 hasConcept C207001950 @default.
• W2127574568 hasConcept C2776235491 @default.
• W2127574568 hasConcept C2779723316 @default.
• W2127574568 hasConcept C2780192828 @default.
• W2127574568 hasConcept C2780616701 @default.
• W2127574568 hasConcept C502942594 @default.
• W2127574568 hasConcept C54009773 @default.
• W2127574568 hasConcept C54355233 @default.
• W2127574568 hasConcept C55493867 @default.
• W2127574568 hasConcept C71924100 @default.
• W2127574568 hasConcept C81885089 @default.
• W2127574568 hasConcept C86803240 @default.
• W2127574568 hasConceptScore W2127574568C104317684 @default.
• W2127574568 hasConceptScore W2127574568C117262875 @default.
• W2127574568 hasConceptScore W2127574568C120405084 @default.
• W2127574568 hasConceptScore W2127574568C121608353 @default.
• W2127574568 hasConceptScore W2127574568C126322002 @default.
• W2127574568 hasConceptScore W2127574568C149011108 @default.
• W2127574568 hasConceptScore W2127574568C150903083 @default.
• W2127574568 hasConceptScore W2127574568C185592680 @default.
• W2127574568 hasConceptScore W2127574568C207001950 @default.
• W2127574568 hasConceptScore W2127574568C2776235491 @default.
• W2127574568 hasConceptScore W2127574568C2779723316 @default.
• W2127574568 hasConceptScore W2127574568C2780192828 @default.
• W2127574568 hasConceptScore W2127574568C2780616701 @default.
• W2127574568 hasConceptScore W2127574568C502942594 @default.
• W2127574568 hasConceptScore W2127574568C54009773 @default.
• W2127574568 hasConceptScore W2127574568C54355233 @default.
• W2127574568 hasConceptScore W2127574568C55493867 @default.
• W2127574568 hasConceptScore W2127574568C71924100 @default.
• W2127574568 hasConceptScore W2127574568C81885089 @default.
• W2127574568 hasConceptScore W2127574568C86803240 @default.
• W2127574568 hasIssue "22" @default.

• next